Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Awakn Life Sciences N.AWKN

Alternate Symbol(s):  AWKNF

Consumer Cyclical
Awakn Life Sciences Corp is a Canadian biotechnology company with clinical operations researching, developing, and delivering psychedelic medicine to treat addiction.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NEO:AWKN)

Fundamentals Snapshot (NEO:AWKN)

Current News (NEO:AWKN)

Awakn Life Sciences Reports Q4 2023 and Annual Results

Newsfile April 28, 2023

IIROC Trade Resumption - AWKN

Canada NewsWire April 26, 2023

Awakn Life Sciences Announces Private Placement

Newsfile April 26, 2023

IIROC Trading Halt - AWKN

Canada NewsWire April 26, 2023

Awakn Life Sciences Signs Collaboration Agreement with University of Exeter for Upcoming Phase III Trial

Newsfile April 18, 2023

Awakn Life Sciences Increases Ownership of Awakn Bristol to 100% and Provides Corporate Update

Newsfile April 12, 2023

Awakn Life Sciences Signs Its Fourth Licensing Partnership Agreement in North America, and First in California

Newsfile February 28, 2023

Awakn Life Sciences (NEO:AWKN) signs first licensing agreement in Europe

John Ballem  February 22, 2023

Awakn Life Sciences Signs Its First Licensing Partnership Agreement in Europe

Newsfile February 21, 2023
View More News ››

Opinion & Analysis (NEO:AWKN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NEO:AWKN)

RE:RE:RE:Seem

This new company  is a sleeping giant to a world of giant wide problem addictions.......Potential is so high with no interest yet......
doggy123 - May 12, 2023

RE:RE:Seem

Man i would like some comments on this stock.............level 2 is crazy so thin that with some good news this thing could pop up $2.00...
doggy123 - May 4, 2023

RE:Seem

Do your own dd.........Analyst Price target $1.75 buying recommendation rating by Yahoo 
doggy123 - May 1, 2023

Seem

Seem a very big potential here with AWKN short future 
doggy123 - May 1, 2023

Microdose Announces The 2nd Annual Microdose Awards

Miami, Florida--(Newsfile Corp. - August 9, 2022) - Microdose Psychedelic Insights, the leading guide to the business of...
Betteryear2 - August 10, 2022

Big news from AWKN!

https://youtu.be/lPV2X3I_0Gk
BryceCanada - July 25, 2022
View more Bullboard ››

NetraMark Holdings Inc.

NetraMark Holdings Inc.

NetraMark is a company focused on being a leader in the development of Artificial Intelligence (AI) / Machine Learning (ML ...
View More »